According to a seven year study led by researchers at Queen Mary University of London, involving more than 3 million people, only 8% of those at greater risk of heart disease who would benefit from taking statins, were prescribed ...
Jun 14, 2021
0
1
Focal segmental glomerulosclerosis (FSGS) is a rare form of kidney inflammation (glomerulonephritis) in which the glomeruli become increasingly scarred (sclerotic), leading to progressive loss of kidney function. Dysregulation ...
Jun 7, 2021
0
3
Health has always been affected by climate and weather, but is increasingly clear that the change in climate is a significant threat to human health. The World Health Organization (WHO) estimates that 24% of global deaths ...
Jun 7, 2021
0
3
IgA nephropathy (IgAN) is a chronic kidney disease occurring in young adults and is one of the most common reasons for kidney transplantation in this age group. IgAN is the most common form of glomerulonephritis (GN), i.e., ...
Jun 7, 2021
0
2
The kidneys are a target organ of COVID-19 and are affected very early in the course. However, this is precisely where there is strong prognostic potential: As early as last spring, COVID-19-associated nephritis was identified ...
Jun 7, 2021
0
4
According to the Global Burden of Disease Study 2017, close to nine percent of the global population lives with some form of chronic kidney disease, or CKD. Not only does the condition affect renal function, but CKD has long ...
Jun 4, 2021
0
13
In a study of adults with normal kidney function, those who had frequent depressive symptoms were more likely to later experience a rapid decline in kidney function. The study will appear in an upcoming issue of CJASN.
May 29, 2021
0
3
Chronic kidney disease (CKD) is caused by diabetes and hypertension. In 2017, the global prevalence of CKD was 9.1 percent, which is approximately 700 million cases. Chronic kidney damage is assessed by scoring the amount ...
May 24, 2021
0
6
Patients with chronic kidney disease and Type 2 diabetes who took the experimental drug finerenone were about 30% less likely to develop the heart rhythm disorder atrial fibrillation (AFib) than those taking a placebo, according ...
May 17, 2021
0
2
Dapagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not significantly reduce the risk of organ failure or death or improve recovery in patients hospitalized with COVID-19 who are at high risk of developing ...
May 17, 2021
0
3
